The civic record
Read. Follow. Verify.Congressional Hearing on Emergent BioSolutions Vaccine Manufacturing Failures
Record date · January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
The House on the Coronavirus Crisis held a hearing to investigate reports that Emergent failed to maintain proper manufacturing standards, leading to the destruction of millions of COVID-19 vaccine doses. The hearing examined the company's use of nearly $650 million in federal taxpayer funds and its inability to meet production expectations.
This hearing addresses the loss of millions of COVID-19 vaccine doses and the oversight of $650 million in federal funds awarded to a private contractor for pandemic response.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Emergent BioSolutions, Inc.
The company is the subject of a congressional investigation regarding its manufacturing practices and use of federal funds.
General Public
The public experienced delays in vaccine availability due to the destruction of doses manufactured by the company.
Key Facts
- The Trump administration awarded Emergent BioSolutions approximately $650 million in federal funds for vaccine manufacturing.
- Millions of COVID-19 vaccine doses were destroyed due to contamination at Emergent facilities.
- Additional millions of vaccine doses were held back for testing to ensure safety.
- The subcommittee investigation cited failures in facility maintenance, staff training, and protocol adherence.
Show all 6 facts
- The hearing was held on May 19, 2021, by the Select Subcommittee on the Coronavirus Crisis.
- The subcommittee released a staff memorandum detailing warnings the company received regarding manufacturing problems.
Frequently Asked Questions
Why were millions of vaccine doses destroyed?
Did this hearing question the safety of the COVID-19 vaccines currently in use?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Oversight of Pandemic Contracting
The document highlights a shift toward increased congressional scrutiny of private contractors receiving large-scale federal funding during the pandemic.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy75Intensity of disagreement among stakeholders
- Entertainment60Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools